A Win For Cytokinetics, Incorporated
Mon, Jul 19, 2021 at 05:30 PM
Cytokinetics, Incorporated (CYTK:NASDAQ) shot up at $27, representing a gain of 40.4%. The stock appeared on our News Catalysts scanner on Mon, Jul 19, 2021 at 03:51 PM in the 'INVESTOR UPDATE' category. From Fri, Jul 02, 2021, the stock recorded 22.22% Up Days and 30.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Cytokinetics, Incorporated (CYTK:NASDAQ)
Cytokinetics Inc is a biopharmaceutical company. It is engaged in the discovery and development of novel small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.
Top 10 Gainers:
- Aehr Test Systems (AEHR:NASDAQ), 87.94%
- NRXP (NRXP:NASDAQ), 45.31%
- Allied Healthcare Products, Inc. (AHPI:NASDAQ), 43.7%
- Cytokinetics, Incorporated (CYTK:NASDAQ), 40.41%
- Mer Telemanagement Solutions Ltd. (MTSL:NASDAQ), 38.44%
- ALF (ALF:NASDAQ), 31.26%
- Aethlon Medical, Inc. (AEMD:NASDAQ), 31.12%
- CRTD (CRTD:NASDAQ), 30.72%
- Alpha Pro Tech, Ltd. (APT:NYSEMKT), 27.34%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%